The impact of previous therapy on overall-survival in registration clinical trials for 1st line metastatic breast cancer a systemic review

Remilah, A. A., Krayim, B., Amir, E., Tibau, A., Robson, M. E., Abuhadra, N., Chen, Y., Shepshelovich, D., & Goldvaser, H. (2024). The impact of previous therapy on overall-survival in registration clinical trials for 1st line metastatic breast cancer a systemic review. Critical Reviews in Oncology/Hematology, 202, 104455. https://doi.org/10.1016/j.critrevonc.2024.104455
Authors:
Areen Abu Remilah
Bilal Krayim
Eitan Amir
Ariadna Tibau
Mark E Robson
Nour Abuhadra
Yuan Chen
Daniel Shepshelovich
Hadar Goldvaser
Affiliated Authors:
Daniel Shepshelovich
Columbia Affiliation:
Author Keywords:
de-novo
drug approval
metastatic breast cancer
registration trials
treatment-naïve
elink
Publication Type:
Article
Unique ID:
10.1016/j.critrevonc.2024.104455
PMID:
39067779
DOI:
10.1016/j.critrevonc.2024.104455
Journal:
Critical Reviews in Oncology/Hematology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: